Taken together, the above findings indicated that elevated levels of EDEM1 contribute to tumor progression and serve as an important indicator for poor prognosis in breast cancer patients, thus providing a potential therapeutic target for cancer prevention. Here, EDEM1 is linked to breast carcinoma.